Selecting patients with extensive-stage small cell lung cancer for prophylactic cranial irradiation by predicting brain metastases

Journal of Thoracic Oncology

Volumn 6, Issue 4, 2011, Pages 808-812

  Greenspoon, Jeffrey N ^a   Evans, William K ^a,b   Cai, Wenjie ^a   Wright, James R ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

Brain metastases; Extensive stage; Prophylactic cranial irradiation; Small cell lung cancer

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PREVENTION; CANCER STAGING; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; SKULL IRRADIATION; SURVIVAL TIME; TREATMENT RESPONSE; WEIGHT REDUCTION;

EID: 79953025472     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31820d782d     Document Type: Article

References (18)

1. Feld R, Pringle JF, Evans WK, et al. Combined modality treatment of small cell carcinoma of the lung. Arch Intern Med 1981;141:469-473. (Pubitemid 11155834)
2. Simon G, Wagner H. Small cell lung cancer. Chest 2003;123:259S-271S. (Pubitemid 36138804)
3. Chute JP, Chen T, Feigal E, et al. Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible prog-ress. J Clin Oncol 1999;17:1794-1801. (Pubitemid 29269249)
4. Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradia-tion for patients with small-cell-lung cancer in complete remission. N Engl J Med 1999;341:476-484. (Pubitemid 29372887)
5. Meert AP, Paesmans M, Berghmans T, et al. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 2001;1:5.
6. Komaki R, Cox JD, Whitson W. Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation. Cancer Treat Rep 1981;65:811-814. (Pubitemid 11050877)
7. Yang GY, Matthews RH. Prophylactic cranial irradiation in small-cell lung cancer. Oncologist 2000;5:293-298. (Pubitemid 30666475)
8. Lee JJ, Bekele BN, Zhou X, et al. Decision analysis for prophylactic cranial irradiation for patients with small-cell lung cancer. J Clin Oncol 2006;24:3597-3603. (Pubitemid 46630532)
9. Felletti R, Souhami RL, Spiro SG, et al. Social consequences of brain or liver relapse in small cell carcinoma of the bronchus. Radiother Oncol 1985;4:335-339. (Pubitemid 16210083)
10. Gregor A, Cull A, Stephens RJ, et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomized trial. Eur J Cancer 1997;33:1752-1758.
11. Arriagada R, LeChevalier T, Riviere A, et al. Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients. Ann Oncol 2002;13:748-754. (Pubitemid 34567382)
12. Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. NEngl JMed 2007;357:664-672. (Pubitemid 47267236)
13. Oken, MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5: 649-655. (Pubitemid 13149996)
14. Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995;33:179-182.
15. Van Oosterhout AG, Can De Pol M, Ten Velde G, et al. Neurologic disorders in 203 consecutive patients with small cell lung cancer: results of a longitudinal study. Cancer 1996;77:1434-1441. (Pubitemid 26105377)
16. Suwinski R, Lee SP, Withers HR. Dose-response relationship for pro-phylactic cranial irradiation in small cell lung cancer. IntJ Radiat Oncol Biol Phys 1998;40:797-806. (Pubitemid 28150796)
17. Brewster AE, Hopwood P, Stout R, et al. Single fraction prophylactic cranial irradiation for small cell carcinoma of the lung. Radiother Oncol 1995;34:132-136.
18. Wright JR, Bouma S, Dayes I, et al. The importance of reporting patient recruitment details in phase III trials. J Clin Oncol 2006;24:843-845. (Pubitemid 46638833)